D
David R. Cheng
Publications - 12
Citations - 1993
David R. Cheng is an academic researcher. The author has contributed to research in topics: CRISPR & Nucleic acid. The author has an hindex of 5, co-authored 11 publications receiving 969 citations.
Papers
More filters
Journal ArticleDOI
Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants.
Kira S. Makarova,Yuri I. Wolf,Jaime Iranzo,Sergey Shmakov,Omer S. Alkhnbashi,Stan J. J. Brouns,Emmanuelle Charpentier,David R. Cheng,Daniel H. Haft,Philippe Horvath,Sylvain Moineau,Francisco J. M. Mojica,David Scott,Shiraz A. Shah,Virginijus Siksnys,Michael P. Terns,Česlovas Venclovas,Malcolm F. White,Alexander F. Yakunin,Alexander F. Yakunin,Winston X. Yan,Feng Zhang,Roger A. Garrett,Rolf Backofen,John van der Oost,Rodolphe Barrangou,Eugene V. Koonin +26 more
TL;DR: An updated evolutionary classification of CRISPR–Cas systems and cas genes is provided, with an emphasis on the major developments that have occurred since the publication of the latest classification, in 2015, which includes 2 classes, 6 types and 33 subtypes.
Journal ArticleDOI
Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein.
Winston X. Yan,Shaorong Chong,Huaibin Zhang,Kira S. Makarova,Eugene V. Koonin,David R. Cheng,David Scott +6 more
TL;DR: The small size, minimal targeting constraints, and modular regulation of Cas13d effectors further expands the CRISPR toolkit for RNA-manipulation and detection.
Journal ArticleDOI
Functionally diverse type V CRISPR-Cas systems
Winston X. Yan,Pratyusha Hunnewell,Lauren E. Alfonse,Jason M. Carte,Elise Keston-Smith,Shanmugapriya Sothiselvam,Anthony J. Garrity,Shaorong Chong,Kira S. Makarova,Eugene V. Koonin,David R. Cheng,David Scott +11 more
TL;DR: The study reveals the functional diversity emerging along different routes of type V CRISPR-Cas evolution and expands theCRISPR toolbox.
Journal ArticleDOI
CRISPR-Cas in mobile genetic elements: counter-defence and beyond.
Guilhem Faure,Guilhem Faure,Sergey Shmakov,Sergey Shmakov,Winston X. Yan,David R. Cheng,David Scott,Joseph E. Peters,Kira S. Makarova,Eugene V. Koonin +9 more
TL;DR: The range of CRISPR–Cas components carried by MGEs is investigated and substantially expanded, finding three groups of Tn7-like transposable elements encode ‘minimal’ type I CRISpr–Cas derivatives capable of target recognition but not cleavage, and another group encodes an inactivated type V variant.
Patent
Novel crispr rna targeting enzymes and systems and uses thereof
TL;DR: The authors describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of a nucleic acid, and describes novel systems, methods and compositions for the manipulation of nucleic acids in a targeted fashion.